News

02.12.2019

“The first steps are slow and then suddenly things start rolling”

“The first steps are slow and then suddenly things start rolling”

After more than 25 years in the pharma business, Andreas Katopodis founded the biotech company Anaveon together with Professor Onur Boyman. In 2019, the startup raised 35 million CHF and will shortly complete the establishment of its new laboratory as the company progresses its products towards clinical development. With a lot of optimistic realism, Andreas takes stock.

mehr >
02.04.2020

University Hospital Basel treats coronavirus patients with plasma

University Hospital Basel treats coronavirus patients with plasma

The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.

mehr >
30.03.2020

Botnar Research Center advancing research into coronavirus

Botnar Research Center advancing research into coronavirus

The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.

mehr >
22.10.2019

Switzerland Innovation Park Basel Area opens site in Jura

Switzerland Innovation Park Basel Area opens site in Jura

Switzerland Innovation Park Basel Area has opened its third location. The park is now represented in Jura alongside its locations in the Cantons of Basel-Landschaft and Basel-Stadt. This represents something of a milestone for the operators BaselArea.swiss.

mehr >
30.03.2020

CEO of Novartis pinning hopes on malaria drug

CEO of Novartis pinning hopes on malaria drug

In the fight against the coronavirus, Vas Narasimhan, CEO of Novartis, is above all pinning his hopes on a malaria drug. Narasimhan has claimed in an interview that this drug has proven in preclinical and initial clinical trials that it can destroy the virus. At the moment, patients are being enrolled for studies.

mehr >
25.03.2020

Cantons in the Basel Area agree aid measures

Cantons in the Basel Area agree aid measures

Basel/Liestal/Delémont – Because of the coronavirus crisis.the three sponsor cantons of BaselArea.swiss have adopted emergency aid measures in addition to those agreed by the Swiss government at national level. The cantons of Basel-Stadt, Basel-Landschaft and Jura will be supporting companies and other individuals affected to a substantial extent. The aim here is to mitigate the consequences of the coronavirus pandemic within the economic region of Basel Area.

mehr >
26.09.2019

GRID boosts innovative power of Basel region

GRID boosts innovative power of Basel region

Work on the construction of the GRID complex for innovation and commerce has begun on the BaseLink site in Allschwil BL. By mid-2022, the Switzerland Innovation Park Basel Area will be operating from the new site as its anchor tenant.

mehr >
23.03.2020

Roivant developing treatment for coronavirus patients

Roivant developing treatment for coronavirus patients

The Basel-based pharmaceutical company Roivant Sciences wants to develop a special antibody for coronavirus patients. This is intended to help treat and prevent acute respiratory distress syndrome.

mehr >
16.03.2020

Roche Coronavirus test gets FDA approval

Roche Coronavirus test gets FDA approval

The US regulatory authority has authorized a test developed by the Basel-based pharmaceutical company Roche to detect the SARS-CoV 2 virus. Due to Roche’s work, numerous additional tests can be carried out in the USA, and for this reason Roche received the express thanks of President Trump.

mehr >
26.09.2019

“The Switzerland Innovation Park Basel Area and the Jura are a match made in heaven”

“The Switzerland Innovation Park Basel Area and the Jura are a match made in heaven”

The Switzerland Innovation Park Basel Area will be opening its Jura site on 25 October. Claude-Henri Schaller, Director of the Office for the Economy and Labour and Vice President of Switzerland Innovation Park Basel Area AG, is convinced that the Innovation Park can make a major contribution to the diversification of industry in the Jura and will create stronger ties between industry and research.

mehr >
09.03.2020

University of Basel investigating active substances against the coronavirus

University of Basel investigating active substances against the coronavirus

The University of Basel is using computer-aided methods in its efforts to find an active substance to fight the coronavirus. A total of just under 700 million substances have been tested on a virtual basis. This has allowed interesting substances to be identified already.

mehr >
24.02.2020

Novartis and Roche are among the most innovative companies

Novartis and Roche are among the most innovative companies

Novartis and Roche feature among the hundred most innovative companies worldwide. This is from the Derwent Top 100 Global Innovators 2020 report. Roche is the only pharmaceutical company worldwide that has appeared in the list nine times.

mehr >
19.09.2019

What we learned at this year’s DayOne Conference

What we learned at this year’s DayOne Conference

Twenty-two panellists and speakers, among them 3 patients and digital health futurist Maneesh Juneja, 30 project champions and their mentors, 40 volunteers and 450 participants and Arcondis as conference Partner  — this was the DayOne Conference which took place on September 9 at the FHNW in Muttenz.

mehr >
21.02.2020

The pharma centers of Basel and India are influencing each other

The pharma centers of Basel and India are influencing each other

Basel has long been one of the world’s most important locations within the pharmaceutical industry. But pharma firms are now starting to play an even bigger role in India as well. Both locations are influencing each other, as shown by the recently ended BioAsia event.

mehr >
20.02.2020

Roche builds “best research center in the world”

Roche builds “best research center in the world”

The pharmaceutical giant Roche has officially started building its new research center in Basel. Around 1,800 researchers should be able to work there by the end of 2023.

mehr >
26.08.2019

"We make no compromises in creating the highest potential company"

Versant Ventures has a strong history in building successful companies such as Therachon, Black Diamond or CRISPR  Therapeutics. We talked to Alex Mayweg, partner at Versant Ventures in Basel, about the beauty of Versant Ventures discovery engine Ridgeline Therapeutics, translating science into successful drug development programs and the future of drug discovery.

mehr >
18.02.2020

Oettinger Davidoff AG: Swiss precision paired with caribbean expertise

Oettinger Davidoff AG: Swiss precision paired with caribbean expertise

Oettinger Davidoff AG, with sales of over half a billion Swiss francs and 3,600 employees around the world, is a Swiss family owned company rooted in Basel. The company is dedicated to the business of producing, marketing, distributing and retailing premium-branded cigars, tobacco products and accessories.

mehr >
13.02.2020

Allthings cooperates with Garaio REM

Allthings cooperates with Garaio REM

Allthings Technologies AG has developed a modular platform for tenants. Now, the Basel company is partnering with Garaio REM AG, a technology partner for property managers. The aim is to guarantee consistent data management.

mehr >
11.06.2019

"I am amazed by the level of innovation in the Jura"

The Switzerland Innovation Park Basel Area already has two sites, in Allschwil and Basel, and will soon add a third in the Jura. It will be located on the Innodel campus in the municipality of Courroux, between Delémont and Courrendlin. Work is ongoing at the Jura site, which is set to officially open on 25 October.

mehr >
11.02.2020

Basel startups to present business concepts in India

Basel startups to present business concepts in India

The Indo-Swiss Healthtech Week will be taking place next week. Connected to this event is BioAsia India, as part of which a select group of five Swiss startups will have the opportunity to present their business concepts. Four of these companies are based in Basel.

mehr >
06.02.2020

Basel research set to improve child vaccines

Basel research set to improve child vaccines

The Basel-based Swiss Tropical and Public Health Institute has uncovered new insights into the immune systems of children. This new understanding could help to improve the efficacy of vaccines. Children are set to benefit from the expertise of Basel research to an even greater extent in the future.

mehr >
06.05.2019

“Here at Bell, we combine handcraft and automation”

“Here at Bell, we combine handcraft and automation”

Over the space of 150 years, a butcher’s in Basel has grown into an international food company, with the Bell Food Group now employing more than 12,000 people in 15 countries. Markus Ettlin, Head of Industry 4.0/Automation at the Bell Food Group, provides an update on the company’s current Industry 4.0 projects, the limits of automation, and innovations in the food sector.

mehr >
30.01.2020

Comment une entreprise jurassienne améliore l'ergonomie

Comment une entreprise jurassienne améliore l'ergonomie

Installée à l’antenne jurassienne du Switzerland Innovation Park Basel Area à Courroux depuis décembre 2019 – et donc l’un des premiers locataires –, la startup Ersys a fait de l’ergonomie sur le lieu de travail son moteur de développement. Rencontre avec son directeur Malik Attouche.

mehr >
29.01.2020

FutureHealth conference brings international experts to Basel

FutureHealth conference brings international experts to Basel

The FutureHealth Basel conference brought together experts, startups and those affected by digital healthcare. In addition to exploring the opportunities and challenges associated with digital healthcare, the conference also focused on strengthening the regional life sciences cluster.

mehr >
02.04.2019

“The Basel region is very advanced in healthcare innovation”

“The Basel region is very advanced in healthcare innovation”

A new master’s degree at the FHNW University of Applied Sciences and Arts Northwestern Switzerland aims to prepare the next generation of professionals in the life sciences industries: Students in “Medical Informatics” are trained to apply the latest technologies during projects for the medical and pharmaceutical industries. Professor Enkelejda Miho from the Institute for Medical and Analytical Technologies at FHNW is confident that the combination of life sciences, informatics and business brings forward a desired new profile of professionals.

mehr >
24.01.2020

New test protects mother and child

New test protects mother and child

MOMM Diagnostics has developed a fast and precise test for diagnosing preeclampsia. It analyzes two biomarkers in a pregnant woman’s blood and can be easily carried out in a doctor’s office.

mehr >
17.01.2020

Novartis opens campus up for innovation

Novartis opens campus up for innovation

Basel-based pharmaceutical Novartis is opening up its campus in Basel to external partners, including Switzerland Innovation Park Basel Area, which will establish an additional office there.

mehr >
28.03.2019

33 recently arrived companies create hundreds of jobs

Basel and the Rhine - attractive for companies (img: Basel Tourismus)

The efforts of BaselArea.swiss proved extremely successful in 2018. 33 companies – seven more than in the previous year – were persuaded to move to the Basel economic region. 16 companies arrived from Europe, nine of which came from Germany. BaselArea.swiss also supported six Swiss companies in the search for a suitable business location in the Basel region. Of the newly arrived companies, 19 operate in the life sciences and chemicals sectors.

mehr >
16.01.2020

TÜV Süd opens office in Basel

TÜV Süd opens office in Basel

TÜV SÜD Management Service GmbH has started the new year with a new office in Basel. Improving service for Swiss customers is the focus.

mehr >
10.01.2020

NBE-Therapeutics raises 22 million dollars

NBE-Therapeutics raises 22 million dollars

The Basel biotech company NBE-Therapeutics has successfully closed a series C financing round. The funds raised will help the company develop its leading product candidate to fight cancer.

mehr >
05.03.2019

Healthcare innovations gain traction with the DayOne Accelerator

Healthcare innovations gain traction with the DayOne Accelerator

Three innovative healthcare startups participate in the first round of the DayOne Accelerator. Faraz Oloumi from Aurteen, Chang Yun from Noul and Christian Vogler and Leo Gschwind from Advancience are examples of how far conviction can get you.

mehr >
09.01.2020

Sotio opens office in Basel

Sotio opens office in Basel

The Czech biotech company Sotio has opened an office in the Technologiepark Basel. Sotio Biotech AG will be responsible for the company’s clinical development.

mehr >
09.01.2020

New at Switzerland Innovation Park Basel Area: Coretag

New at Switzerland Innovation Park Basel Area: Coretag

Coretag, a new dynamic biotech company, launches a radioligand platform technology for a range of therapeutic and diagnostic purposes. A radioligand is a radioactive biochemical that is used for diagnostic and therapeutic procedures or for studying the body’s receptor systems. Injected into the relevant tissue or administered into the bloodstream, the radioligand binds to its receptor on tumor cells surfaces. Coretag is determined to rapidly improve care with this platform technology.

mehr >
05.02.2019

“We are a small company with a big portfolio”

“We are a small company with a big portfolio”

After Martine and Jean-Paul Clozel created Actelion with two other founders and grew Actelion into Europe’s biggest biotech, the company and its late-stage pipeline were acquired by Johnson&Johnson in 2017. With Actelion’s discovery- and early-stage R&D assets, the couple formed Idorsia, with the vision to build one of Europe’s leading biopharmaceutical companies

mehr >
20.12.2019

Basel leads in international tax competition

Basel leads in international tax competition

The canton of Basel-Stadt offers one of the world’s most attractive tax burdens for companies, according to the latest BAK Taxation Index. With an effective tax burden of 11 per cent, it has ranked seventh in the world for the first time.

mehr >
19.12.2019

Cellestia Biotech secures new funds

Cellestia Biotech secures new funds

The Basel startup Cellestia Biotech has raised 20 million Swiss francs in a financing round. It plans to use the funds to advance the development of its agent CB-103 for the treatment of specific types of cancer.

mehr >
08.01.2019

"It doesn't always have to stay the same"

Désirée Mettraux has been the CEO of Creadi since 2016. The Pax spin-off has developed the Simpego online insurance platform. The insurance expert is confident that the industry will profit if it opens itself up to partners. The aim is to make insurance fun.

mehr >
18.12.2019

Basel is evolving into a pediatrics hub

Basel is evolving into a pediatrics hub

The Botnar Research Center for Child Health in Basel has started its research activities. The first four projects have now been selected. Together with the DayOne Accelerator from BaselArea.swiss, Basel is gradually evolving into a pediatrics hub.

mehr >
17.12.2019

Basel leading the way on quantum technology

Basel leading the way on quantum technology

The federal government has launched six new National Centers of Competence in Research. Two of these are to be located at the University of Basel. This will now see the groundwork on new information-processing technology conducted in Basel.

mehr >
03.12.2018

“Momentum for blockchain in healthcare is growing in Basel”

“Momentum for blockchain in healthcare is growing in Basel”

Marco Cuomo and Daniel Fritz from Novartis got engaged in blockchain two years ago. Today, their aim is set high: With other pharma companies under the Innovative Medicines Initiative, they formed a “Blockchain Enabled Healthcare” program, due to kick off in 2019. The program that they presented at the Blockchain Leadership Summit in Basel – Switzerland’s largest conference in this field - wants no less than to define how blockchain is applied in healthcare.

mehr >

 

(Source: http://www.baselarea.swiss/en/baselarea-swiss/channels/innovation-report.html)